These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 16142312)

  • 1. Magnetically labeled human natural killer cells, accumulated in vitro by an external magnetic force, are effective against HOS osteosarcoma cells.
    Nakashima Y; Deie M; Yanada S; Sharman P; Ochi M
    Int J Oncol; 2005 Oct; 27(4):965-71. PubMed ID: 16142312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
    Lin SJ; Kuo ML
    Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lytic activity of IL-2 and IL-12 stimulated NK cells against HOS osteosarcoma cell line.
    Mariani E; Tarozzi A; Meneghetti A; Tadolini M; Facchini A
    Boll Soc Ital Biol Sper; 1996; 72(1-2):21-7. PubMed ID: 8868111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Wilms tumor cell line, HFWT, can greatly stimulate proliferation of CD56+ human natural killer cells and their novel precursors in blood mononuclear cells.
    Harada H; Watanabe S; Saijo K; Ishiwata I; Ohno T
    Exp Hematol; 2004 Jul; 32(7):614-21. PubMed ID: 15246157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation between the percent of CD3- CD56+ cells and NK precursor function.
    Gharehbaghian A; Donaldson C; Newman J; Bannister G; Bradley BA
    Iran J Allergy Asthma Immunol; 2006 Dec; 5(4):167-75. PubMed ID: 17237569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-12 and interleukin-18 change ICAM-I expression, and enhance natural killer cell mediated cytolysis of human osteosarcoma cells.
    Liebau C; Merk H; Schmidt S; Roesel C; Karreman C; Prisack JB; Bojar H; Baltzer AW
    Cytokines Cell Mol Ther; 2002; 7(4):135-42. PubMed ID: 14660053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparative study of immunomagnetic methods used for separation of human natural killer cells from peripheral blood.
    Øren A; Husebø C; Iversen AC; Austgulen R
    J Immunol Methods; 2005 Aug; 303(1-2):1-10. PubMed ID: 16054641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo expansion of natural killer cells for clinical applications.
    Klingemann HG; Martinson J
    Cytotherapy; 2004; 6(1):15-22. PubMed ID: 14985163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of human CD56+ cell cytotoxicity and IFN-gamma production.
    Derby EG; Reddy V; Nelson EL; Kopp WC; Baseler MW; Dawson JR; Malyguine AM
    Cytokine; 2001 Jan; 13(2):85-90. PubMed ID: 11145847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel five-colour flow cytometric assay to determine NK cell cytotoxicity against neuroblastoma and other adherent tumour cells.
    Klöss S; Bochennek K; Huenecke S; Zimmermann SY; Kuçi S; Müller T; Wels WS; Klingebiel T; Esser R; Koehl U
    J Immunol Methods; 2007 Aug; 325(1-2):140-7. PubMed ID: 17663991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of human natural killer cells using a clinical-scale immunomagnetic method.
    Iyengar R; Handgretinger R; Babarin-Dorner A; Leimig T; Otto M; Geiger TL; Holladay MS; Houston J; Leung W
    Cytotherapy; 2003; 5(6):479-84. PubMed ID: 14660043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cytotoxic NK-cell line (NK-92) for ex vivo purging of leukemia from blood.
    Klingemann HG; Wong E; Maki G
    Biol Blood Marrow Transplant; 1996 May; 2(2):68-75. PubMed ID: 9118301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperthermia increases the susceptibility of chondro- and osteosarcoma cells to natural killer cell-mediated lysis.
    Kubista B; Trieb K; Blahovec H; Kotz R; Micksche M
    Anticancer Res; 2002; 22(2A):789-92. PubMed ID: 12014651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Method for expansion in vitro of CD3-CD56+CD16+NK cells highly purified from human peripheral blood].
    Xiong D; Yang ZG; Li QH; Wu ZC; Lü JT
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Oct; 18(5):1310-5. PubMed ID: 21129283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo expansion of highly purified NK cells for immunotherapy after haploidentical stem cell transplantation in children.
    Koehl U; Esser R; Zimmermann S; Tonn T; Kotchetkov R; Bartling T; Sörensen J; Grüttner HP; Bader P; Seifried E; Martin H; Lang P; Passweg JR; Klingebiel T; Schwabe D
    Klin Padiatr; 2005; 217(6):345-50. PubMed ID: 16307421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cytolytic activity of human NK cells against osteosarcoma cell lines.
    Tarozzi A; Mariani E; Facchini A
    Boll Soc Ital Biol Sper; 1995; 71(7-8):221-6. PubMed ID: 8519499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cytotoxicity of allogenetic natural killer cells against CD34+ acute myelogenous leukemia cells].
    Niu XQ; Guo KY; Zhou J; Hu LS; Tu SF; She MR
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Feb; 28(2):173-5. PubMed ID: 18250035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience.
    McKenna DH; Sumstad D; Bostrom N; Kadidlo DM; Fautsch S; McNearney S; Dewaard R; McGlave PB; Weisdorf DJ; Wagner JE; McCullough J; Miller JS
    Transfusion; 2007 Mar; 47(3):520-8. PubMed ID: 17319835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural killer cell mediated cytotoxicity of tumor cells initiated by neem leaf preparation is associated with CD40-CD40L-mediated endogenous production of interleukin-12.
    Bose A; Baral R
    Hum Immunol; 2007 Oct; 68(10):823-31. PubMed ID: 17961770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-23 modulates CD56+/CD3- NK cell and CD56+/CD3+ NK-like T cell function differentially from IL-12.
    van de Wetering D; de Paus RA; van Dissel JT; van de Vosse E
    Int Immunol; 2009 Feb; 21(2):145-53. PubMed ID: 19088061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.